Sign in

CIK 0000939767

  • Large accelerated filer

EXELIXIS, INC.

Sign in to watch
Ticker
EXEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jan 1
Incorporated
DE
Entity type
Operating
EIN
043257395
Phone
+1 650-837-7000
Business address
1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
Former names
EXELIXIS INC
  1. 4 Grant or award Director acquired 9,812 shares (grant or award)
  2. 4 Grant or award Director acquired 9,812 shares (grant or award)
  3. 4 Grant or award Director acquired 9,812 shares (grant or award)
  4. 4 Grant or award Director acquired 9,812 shares (grant or award)
  5. 4 Grant or award Director acquired 9,812 shares (grant or award)
  6. 4 Grant or award Director acquired 9,812 shares (grant or award)
  7. 4 Grant or award Director acquired 9,812 shares (grant or award)
  8. 4 Open-market sale EVP, Commercial sold 34,387 shares at $44.06 ($1,515,091)
  9. 4 Open-market sale Director sold 4,544 shares at $44.29 ($201,254)
  10. 4 Open-market sale Director sold 20,634 shares at $45.99 ($948,958)
  11. 4 Shares withheld for taxes CSO/EVP Disc & Trans Research gave up 30,693 shares (to pay taxes)
  12. 4 Open-market sale EVP and CFO sold 100,000 shares at $46.00 ($4,600,000)
  13. 4 Open-market sale Director sold 36,508 shares at $44.35 ($1,619,130)
  14. 4 Shares withheld for taxes President and CEO gave up 325,263 shares (to pay taxes)
  15. 4 Open-market sale EVP & General Counsel sold 25,000 shares at $46.18 ($1,154,500)
  16. 4 Planned sale EVP, Commercial sold 136,383 shares at an average $47.58 ($6,488,503)
  17. 4 Open-market sale EVP Prod Dev & Med Aff & CMO sold 72,776 shares at $45.47 ($3,309,125)
  18. 4 Planned sale CSO/EVP Disc & Trans Research sold 1,508 shares at $39.00 ($58,812)
  19. 4 Grant or award EVP Prod Dev & Med Aff & CMO acquired 159,383 shares (grant or award)
  20. 4 Grant or award President and CEO acquired 589,719 shares (grant or award)

Page 4 of 73 · 1,458 filings